Rockwell Medical Inc (RMTI) - Total Liabilities

Latest as of March 2026: $21.57 Million USD

Based on the latest financial reports, Rockwell Medical Inc (RMTI) has total liabilities worth $21.57 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Rockwell Medical Inc - Total Liabilities Trend (1997–2025)

This chart illustrates how Rockwell Medical Inc's total liabilities have evolved over time, based on quarterly financial data. See Rockwell Medical Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Rockwell Medical Inc Competitors by Total Liabilities

The table below lists competitors of Rockwell Medical Inc ranked by their total liabilities.

Company Country Total Liabilities
Eminent Gold Corp
V:EMNT
Canada CA$309.16K
NTG Clarity Networks Inc.
V:NCI
Canada CA$17.26 Million
TPC Consolidated Ltd
AU:TPC
Australia AU$39.31 Million
Superlon Holdings Bhd
KLSE:7235
Malaysia RM46.34 Million
Tongyang Pile Inc
KQ:228340
Korea ₩5.49 Billion
Dexter Co Ltd
KQ:206560
Korea ₩67.64 Billion
Grande Group Limited Class A Ordinary Shares
NASDAQ:GRAN
USA $327.05K
Mohenz.Co.Ltd
KQ:006920
Korea ₩19.16 Billion

Liability Composition Analysis (1997–2025)

This chart breaks down Rockwell Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Rockwell Medical Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.74 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.60 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.38 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Rockwell Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Rockwell Medical Inc (1997–2025)

The table below shows the annual total liabilities of Rockwell Medical Inc from 1997 to 2025.

Year Total Liabilities Change
2025-12-31 $20.16 Million -24.26%
2024-12-31 $26.62 Million -13.79%
2023-12-31 $30.88 Million -5.06%
2022-12-31 $32.53 Million -29.34%
2021-12-31 $46.04 Million +5.65%
2020-12-31 $43.58 Million +81.60%
2019-12-31 $24.00 Million -5.08%
2018-12-31 $25.28 Million -2.26%
2017-12-31 $25.87 Million -14.34%
2016-12-31 $30.20 Million +18.41%
2015-12-31 $25.50 Million -12.95%
2014-12-31 $29.30 Million -18.09%
2013-12-31 $35.77 Million +32.53%
2012-12-31 $26.99 Million +97.06%
2011-12-31 $13.69 Million +113.01%
2010-12-31 $6.43 Million +15.71%
2009-12-31 $5.56 Million -22.17%
2008-12-31 $7.14 Million +47.44%
2007-12-31 $4.84 Million +1.33%
2006-12-31 $4.78 Million -11.76%
2005-12-31 $5.42 Million +26.59%
2004-12-31 $4.28 Million +10.47%
2003-12-31 $3.87 Million +13.63%
2002-12-31 $3.41 Million -1.54%
2001-12-31 $3.46 Million +190.71%
2000-12-31 $1.19 Million +32.30%
1999-12-31 $900.00K +28.57%
1998-12-31 $700.00K -63.16%
1997-12-31 $1.90 Million --

About Rockwell Medical Inc

NASDAQ:RMTI USA Drug Manufacturers - Specialty & Generic
Market Cap
$25.68 Million
Market Cap Rank
#24347 Global
#5160 in USA
Share Price
$0.65
Change (1 day)
-3.93%
52-Week Range
$0.62 - $1.83
All Time High
$141.02
About

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate conce… Read more